BioRestorative closes $23M public offering, swaps $10M notes for equity

BioRestorative Therapies, Inc.

Closed underwritten public offering of 2.3M units at $10 each, gross proceeds ~$23M. Each unit: 1 common share + 1 warrant.
Exchanged $10.0M convertible notes and $7.8M warrants for 313,780 common shares, 1.54M Series A preferred shares, and new warrants.
Offering and exchange priced at $10.00 per unit; new warrants exercisable at $10 over 5 years.
Common stock now listed on Nasdaq under ticker BRTX.
Roth Capital Partners acted as sole underwriter for the offering.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.